RETATRUTIDE 20MG - User Manual & Research Protocol Guide

 Product Information

• Compound: Retatrutide
• Strength: 20 mg per vial
• Form: Lyophilized powder
• Category: GLP-1 / GIP / Glucagon Receptor Agonist (Research)
• Intended Use: Laboratory research only
• Storage (Unmixed): 2–8°C
• Storage (After Reconstitution): Refrigerate, use within 30 days

Retatrutide is being studied as a triple receptor agonist targeting:

• GLP-1 receptor – Appetite & glucose regulation
• GIP receptor – Metabolic modulation
• Glucagon receptor – Energy expenditure research

This multi-pathway activation is under investigation for metabolic and body composition studies.

Supplies Needed

• Bacteriostatic Water
• U-100 Insulin Syringe
• Alcohol Swabs

Step-by-Step Instructions

1. Clean vial tops with alcohol.
2. Draw bacteriostatic water into syringe.
3. Slowly inject water along inside wall of vial.
4. Gently swirl until fully dissolved.
   ❗ Do NOT shake.
5. Refrigerate after mixing.

(Research Reference Structure Only – Not Medical Advice)

Option 1: Add 4 mL Bacteriostatic Water

Total Peptide: 20 mg

Final Concentration: 5 mg per mL

U-100 Syringe Conversion (approximate):

• 10 units (0.1 mL) = 0.5 mg
• 20 units (0.2 mL) = 1 mg
• 30 units (0.3 mL) = 1.5 mg
• 40 units (0.4 mL) = 2 mg
• 50 units (0.5 mL) = 2.5 mg
  

Option 2: Add 2 mL Bacteriostatic Water

Final Concentration: 10 mg per mL

U-100 Syringe Conversion (approximate):

• 5 units (0.05 mL) = 0.5 mg
• 10 units (0.1 mL) = 1 mg
• 15 units (0.15 mL) = 1.5 mg
• 20 units (0.2 mL) = 2 mg

• Frequently studied as once-weekly subcutaneous administration
• Gradual titration models evaluated in controlled research
• Observation period typically 8–24 weeks

• For laboratory research use only
• Not for human consumption
• Not FDA approved for therapeutic use
• Maintain sterile technique
• Store refrigerated
• Keep out of reach of children